Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice

BACKGROUND: The toxic effect of doxorubicin on the heart limits its clinical usage in cancer therapy. This work intended to investigate, for the first time, the efficacy of rifampicin administration against doxorubicin-induction of cardiotoxicity in mice. Forty adult male albino mice were distribute...

Descripción completa

Detalles Bibliográficos
Autores principales: Basal, Omnia A., Zahran, Rasha F., Saad, Entsar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441914/
https://www.ncbi.nlm.nih.gov/pubmed/37603165
http://dx.doi.org/10.1186/s43044-023-00403-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441914/
https://www.ncbi.nlm.nih.gov/pubmed/37603165
http://dx.doi.org/10.1186/s43044-023-00403-z

Ejemplares similares